Massive study tracks IBD drug safety in kids for years

NCT ID NCT00606346

Ongoing Knowledge-focused Sponsor: Janssen Biotech, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study follows nearly 5,000 children with Crohn's disease, ulcerative colitis, or indeterminate colitis to monitor the long-term safety of their treatments, including the drug infliximab. Researchers collect information on side effects, disease activity, and quality of life over time. The goal is to better understand how these therapies affect children in the real world.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease indeterminate colitis inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN'S DISEASE INDETERMINATE COLITIS INFLAMMATORY BOWEL DISEASES ULCERATIVE COLITIS

Contacts and locations

Locations

Study site

Mobile, Alabama, United States
Study site

Phoenix, Arizona, United States
Study site

Los Angeles, California, United States
Study site

Oakland, California, United States
Study site

Sacramento, California, United States
Study site

San Diego, California, United States
Study site

San Francisco, California, United States
Study site

Aurora, Colorado, United States
Study site

Hartford, Connecticut, United States
Study site

New Haven, Connecticut, United States
Study site

Gainesville, Florida, United States
Study site

Miami, Florida, United States
Study site

Orlando, Florida, United States
Study site

Atlanta, Georgia, United States
Study site

Boise, Idaho, United States
Study site

Chicago, Illinois, United States
Study site

Lexington, Kentucky, United States
Study site

New Orleans, Louisiana, United States
Study site

Portland, Maine, United States
Study site

Boston, Massachusetts, United States
Study site

Newton, Massachusetts, United States
Study site

Worcester, Massachusetts, United States
Study site

Detroit, Michigan, United States
Study site

Southfield, Michigan, United States
Study site

Minneapolis, Minnesota, United States
Study site

Rochester, Minnesota, United States
Study site

Boys Town, Nebraska, United States
Study site

Las Vegas, Nevada, United States
Study site

Manchester, New Hampshire, United States
Study site

Mays Landing, New Jersey, United States
Study site

Morristown, New Jersey, United States
Study site

Brooklyn, New York, United States
Study site

Buffalo, New York, United States
Study site

Lake Success, New York, United States
Study site

Mineola, New York, United States
Study site

New York, New York, United States
Study site

Stony Brook, New York, United States
Study site

Syracuse, New York, United States
Study site

The Bronx, New York, United States
Study site

Williamsville, New York, United States
Study site

Chapel Hill, North Carolina, United States
Study site

Durham, North Carolina, United States
Study site

Oklahoma City, Oklahoma, United States
Study site

Danville, Pennsylvania, United States
Study site

Philadelphia, Pennsylvania, United States
Study site

Greenville, South Carolina, United States
Study site

Knoxville, Tennessee, United States
Study site

Memphis, Tennessee, United States
Study site

Dallas, Texas, United States
Study site

Fort Worth, Texas, United States
Study site

San Antonio, Texas, United States
Study site

Burlington, Vermont, United States
Study site

Charlottesville, Virginia, United States
Study site

Fairfax, Virginia, United States
Study site

Norfolk, Virginia, United States
Study site

Seattle, Washington, United States
Study site

Madison, Wisconsin, United States
Study site

Milwaukee, Wisconsin, United States
Study site

Edmonton, Alberta, Canada
Study site

Halifax, Nova Scotia, Canada
Study site

Burlington, Ontario, Canada
Study site

Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.